Legend Biotech (LEGN) Shares Issued (2020 - 2025)

Legend Biotech (LEGN) has 6 years of Shares Issued data on file, last reported at $1.3 million in Q3 2025.

• In Q3 2025, Shares Issued fell 76.48% year-over-year to $1.3 million; the TTM figure through Sep 2025 stood at $3.6 million (down 63.1% YoY), while the FY2024 annual figure was $9.7 million, down 17.77% from the prior year.
• Shares Issued rose to $1.3 million in Q3 2025, from $273000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $8.1 million in Q2 2023 and bottomed at $273000.0 in Q2 2025.
• A 5-year average of $1.7 million and a median of $923000.0 in 2022 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2023 — Shares Issued surged 667.48% — and 2025, when it sank 87.09%.
• Year by year, Shares Issued stood at $378000.0 in 2021, then soared by 65.08% to $624000.0 in 2022, then decreased by 0.48% to $621000.0 in 2023, then declined by 2.9% to $603000.0 in 2024, then surged by 110.95% to $1.3 million in 2025.
• The last three Shares Issued figures came in at $1.3 million (Q3 2025), $273000.0 (Q2 2025), and $1.4 million (Q1 2025), per Business Quant data.

Peer Comparison